From a translational standpoint, approaches that enhance TRPM2-dependent signaling in atrial cells or otherwise amplify the ANP axis could help boost ANP output and mitigate pathological remodeling in heart failure or hypertension. The gene discussed is NPPA; the disease is heart failure.